MelanieWainKierMDMBA

PubMed

• 446 citations
  A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
  Alexander C. Huang, Robert J. Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George
  Nature Medicine. 2019-02-25
• 1 citations
  Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8T cells.
  Kevin Wang, Paulina Coutifaris, David Brocks, Guanning Wang, Tarek Azar
  Cancer Cell. 2024-09-09
• 3 citations
  Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.
  Rima Patel, Malin Hovstadius, Melanie W Kier, Erin L Moshier, Brittney S Zimmerman
  Cancer. 2022-10-01

Journal Articles

• A. Case of Paraneoplastic Cerebellar Disorder in Ovarian Carcinoma with a Negative Serum Paraneoplastic Antibody Panel and a Positive CSF Anti-Yo Antibody Titer  
  Berger N*, Kier MW*, Kim L, Tiersten A., Journal of Gynecological Oncology, 7/18/2022

Abstracts/Posters

• Socioeconomic disparities in supportive therapy use and tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer
  Kier MW, Li Z, Casasanta N, Patel R, Agarwal P, Zimmerman BS, Yang Y, Fink MY, Zhou X, Newman S, Chen R, Schadt E, Oh WK, Tiersten A, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 6/6/2022
• Correlation of Ki67 working group prognostic risk categories with oncotype DX recurrence score (RS) in early breast cancer (EBC)
  Patel R, Hovstadius M, Kier MW, Moshier E, Zimmerman BS, Cascetta KP, Jaffer S, Sparano JA, Tiersten A, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 6/6/2022
• The Promising Use of Hospital at Home in an Oncology Setting
  Kier MW, Lubetsky S, Schiller G, Siu AL, Ornstein KA, Smith CB, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 6/4/2022
• Relationship Between Hematologic Toxicity and Pathologic Complete Response During Neoadjuvant Treatment for Triple Negative Breast Cancer
  Kier MW, Li Z, Patel R, Blanter J, Casasanta N, Fink MY, Zhou Z, Chen R, Schadt E, Oh WK, Tiersten A, Icahn School of Medicine Institute for Department of Medicine Research Day, New York, NY, 5/25/2022
• Using Two Genomic Assays to Guide Adjuvant Chemotherapy Decisions in Patients with Early-Stage Hormone-Receptor Positive Breast Cancer
  Patel R, Zimmerman BS, Wells JD, Kier MW, Li Z, Fink MY, Xiang Z, Redfern A, Newman S, Chen R, Oh WK, Tiersten A, Icahn School of Medicine Institute for Department of Medicine Research Day, New York, NY, 5/25/2022
• Impact of supportive therapies on tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer
  Kier MW, Li Zhiqiang, Zimmerman BS, Patel R, Yang Y, Fink MY, Wells JD, Zhou X, Newman S, Chen R, Schadt E, Oh W, Tiersten A, San Antonio Breast Cancer Symposium, San Antonio, TX, 12/10/2021
• Impact of Prior Radiation Pneumonitis on Incidence of Immunotherapy Related Pneumonitis
  Kier MW, Marmarelis ME, Davis C, Jain V, Berman A, Bauml JM, Singh A, Ciunci C, Aggarwal C, Langer CJ, Cohen RB., World Conference on Lung Cancer, International Association for the Study of Lung Cancer, Barcelona, ESP, 9/2019
• STK11/LKB1 Genomic Alterations are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
  Skoulidis F, Arbour KC, Hellman MD, Patil P, Marmarelis ME, et al, Kier MW, et al, Papadimitrakopoulou V, Heymach JV., World Conference on Lung Cancer, International Association for the Study of Lung Cancer, Barcelona, ESP, 9/2019
• Join now to see all

Other

• Training Future Quality Leaders in Oncology Starts with Fellowship 
  Kessler AJ*, Kier MW*, Smith CB, Bhardwaj AS, Expert Editorial in ASCO Daily News
  https://dailynews.ascopubs.org/do/10.1200/ADN.21.200725/full/
  10/7/2021
• Utilization of Pathologist to Help Grieving Family Understand Autopsy Finding 
  Kier MW, Wain S, Oral Presentation
  Planetree International Conference, October 2016